Very recently, it has been reported that niclosamide was able to inhibit Wnt/β-catenin signaling in colorectal cancer cells, inhibited colorectal cancer growth and S100A4-mediated metastatic colorectal cancer [23], [24]. The gene discussed is S100A4; the disease is metastatic colorectal cancer.